GenPrime, Inc. has recently added two new Directors to its Board.  The two new members are Tom Tiffany, CEO of PAML and Tom Simpson, founder of Northwest Venture Associates. 

Dr. Tom Tiffany brings to GenPrime his extensive expertise in the rapidly growing In Vitro Diagnostics (IVD) clinical market.  Dr. Tiffany has been general manager and then President/CEO of PAML since June 1987. PAML is one of the top 10 clinical laboratories in the US, with six partnerships, billings over $200 M (US) and 1600 employees. He has been in the Biomedical field thirty nine (39) years; 23 years with PAML and  ten years with Instrumentation Laboratory (Spokane/Lexington MA).  GenPrime is moving into the IVD market with its new Point-of-Care Diagnostic Test Reader.  The Reader uses a novel image analysis algorithm that allows clinicians to quickly obtain accurate, non-subjective results in electronic format for data sharing and archiving.  The product reads diagnostic tests from multiple manufacturers and has applications in clinical markets such as Drugs of Abuse, Women's Health, Cardiac, Infectious Disease and Oncology.  “Dr. Tiffany has already brought a wealth of experience to GenPrime with his and PAML’s support of our Diagnostic Reader project”, says Buck Somes, CEO of GenPrime.  “The addition of him to our Board will be immensely helpful in executing our growth strategy.”

Tom Simpson brings to GenPrime his expertise in raising and managing capital.  Tom has over 22 years of experience as an investment banker, a venture capitalist and an angel investor.  Most recently, he co-founded GreenCupboards, an on-line retailer of environmentally friendly products for homes and businesses.  Tom's investment activities are conducted through Northwest Venture Associates (NWVA).  NWVA has raised and invested over $150 million in emerging companies throughout the Northwest.  He is President of the Spokane Angel Alliance and serves on the Boards of the Technology Alliance of Washington and the Mobius Science Center and on the Advisory Board for the University of Washington Foster School of Business.  “Tom is a great addition to GenPrime’s Board of Directors”, says GenPrime’s Chairman, Johnny Humphreys.  “His experience as an institutional investor will go a long way in helping the Company with its growth-capital raising strategy.”

About GenPrime

GenPrime, Inc. is a leading provider of microbial detection and diagnostic analysis technologies. These state-of-the-art technologies are behind today's best analysis products, and are forming tomorrow's cutting-edge designs. Users of GenPrime's advanced solutions include government agencies, police & fire departments, municipalities, hospitals, laboratories, ethanol production facilities, and breweries. GenPrime is privately held and located in Spokane, Washington.